Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze VRDN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate VRDN investment potential.

What is VRDN stock price today?

Get real-time VRDN stock price, historical data, and price charts on Financhill. Track VRDN performance with our advanced analysis tools.

Is VRDN a good investment?

Evaluate VRDN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy VRDN stock?

To buy VRDN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of VRDN?

View detailed market capitalization data and company valuation metrics for VRDN on our comprehensive analysis page.

What is the P/E ratio of VRDN?

Use our fundamental analysis tools to view VRDN P/E ratio and compare valuation metrics with industry peers.

What are VRDN earnings?

View VRDN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Viridian Therapeutics, Inc. Stock Predictions

Safe Investing Checklist - Stay Clear of Risky Stocks

Get Your Free Safe Stock Selector Checklist Now

Sell

VRDN
Viridian Therapeutics, Inc.

Last Price:

$31.87

Seasonality Move:

1.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Get Your Free Stock Selector Checklist and Invest Smarter

Get Your Free Safe Stock Selector Checklist Now

Viridian Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically fallen by 9.3% based on the past 11 years of stock performance.
Viridian Therapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Is Viridian Therapeutics, Inc. Stock Undervalued?

The current Viridian Therapeutics, Inc. [VRDN] share price is $32.02. The Score for VRDN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
VRDN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Viridian Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically fallen by 9.3% based on the past 11 years of stock performance.

Viridian Therapeutics, Inc. Stock Rating

Sell

Viridian Therapeutics, Inc. (VRDN) is a Sell

Is Viridian Therapeutics, Inc. overpriced?

Viridian Therapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

Viridian Therapeutics, Inc. Stock Price History

Is VRDN stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRDN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

viridiantherapeutics.com

52-Week Data

52-Week High:

33.34

52-Week Low:

9.90

Prediction Charts

Market Cap:

3.1B

Price in USD:

32.02

Volume:

673.8K

Beta:

1.24

Technical Analysis

SMA50:

25.47

SMA100:

21.86

SMA200:

18.11

52-Wk Change:

63.12%

Stock Predictions

Is Viridian Therapeutics, Inc. stock public?

Yes, Viridian Therapeutics, Inc. is a publicly traded company.
What is the Viridian Therapeutics, Inc. stock quote today?

The Viridian Therapeutics, Inc. stock price is 32.02 USD today.
How to buy Viridian Therapeutics, Inc. stock online?

You can buy Viridian Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-17	28.85	29.00	29.58	28.59
Nov-18	28.98	28.59	29.08	28.54
Nov-19	28.55	28.68	29.00	28.33
Nov-20	29.10	29.47	29.90	28.71
Nov-21	29.31	30.34	30.77	29.00
Nov-24	30.91	32.03	32.54	30.76
Nov-25	32.07	31.41	32.29	30.94
Nov-26	31.49	31.72	32.02	31.11
Nov-28	32.00	31.96	32.09	31.60
Dec-1	31.56	31.45	31.94	31.06
Dec-2	31.53	30.43	31.94	30.22
Dec-3	30.97	31.30	31.65	30.68
Dec-4	31.30	32.46	33.34	30.91
Dec-5	32.44	32.02	32.97	31.95

Viridian Therapeutics, Inc. Earnings

Viridian Therapeutics, Inc. Earnings Report: Per Share Viridian Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Viridian Therapeutics, Inc. Forecast Revenue Growth

Viridian Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viridian Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.

* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.